Hologic (HOLX) PT Raised to $48 at RBC Capital

Go back to Hologic (HOLX) PT Raised to $48 at RBC Capital

Hologic (HOLX) PT Raised to $50 at Needham & Company

January 31, 2019 8:21 AM EST

Needham & Company analyst Mike Matson raised the price target on Hologic (NASDAQ: HOLX) to $50.00 (from $48.00) while maintaining a Buy rating.

Matson commented, " HOLX's F4Q18 revenue was consistent with its 1/7/19 preannouncement while EPS beat consensus. Management raised its FY19 revenue and EPS guidance.... More

Hologic (HOLX) PT Raised to $46 at Cowen

January 31, 2019 8:18 AM EST

Cowen analyst Doug Schenkel raised the price target on Hologic (NASDAQ: HOLX) to $46.00 (from $43.00) while maintaining a Market Perform rating.

... More

Hologic (HOLX) PT Raised to $47 at UBS

January 31, 2019 6:21 AM EST

UBS raised its price target on Hologic (NASDAQ: HOLX) to $47.00 (from $44.00) while maintaining a Neutral rating.

... More

Hologic (HOLX) Tops Q1 EPS by 1c

January 30, 2019 4:02 PM EST

Hologic (NASDAQ: HOLX) reported Q1 EPS of $0.58, $0.01 better than the analyst estimate of $0.57. Revenue for the quarter came in at $830.7 million versus the consensus estimate of $817.94 million.

GUIDANCE:

Hologic sees Q2 2019 EPS of $0.55-$0.57, versus the consensus of... More